Similar Items: Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver
- Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
- Histopathologic growth patterns as prognostic factor for survival in patients with colorectal liver metastases
- Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer
- Serum ATIC Expression as a Novel Diagnostic and Prognostic Biomarker in Multiple Myeloma Patients
- Knowledge and awareness of colorectal cancer in central Uganda: a community cross-sectional survey
- Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer